Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 2 , Pages 75-81, August 2010

Cide-a and Cide-c are induced in the progression of hepatic steatosis and inhibited by eicosapentaenoic acid

  • Yasutaka Jinno

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
  • ,
  • Masanori Nakakuki

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81550897881; fax: +81550898070.
  • ,
  • Ayumi Sato

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
  • ,
  • Hiroyuki Kawano

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
  • ,
  • Tatsuto Notsu

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
  • ,
  • Kiyoshi Mizuguchi

      Affiliations

    • Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Shizuoka 412-8524, Japan
  • ,
  • Hitoshi Shimano

      Affiliations

    • Department of Internal Medicine (Endocrinology and Metabolism), Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan

Received 13 April 2010; accepted 24 May 2010. published online 14 June 2010.

Abstract 

Cide-a and Cide-c belong to the cell death-inducing DNA fragmentation factor-α-like effector family. Recent evidences suggest that these proteins may be involved in lipid accumulation in liver and adipose tissues. We confirmed that in the high-fat/high-sucrose diet-induced murine model of hepatic steatosis, the expression levels of the Cide-a and Cide-c genes were markedly and time-dependently increased, but returned to normal levels following improvement of hepatic steatosis by eicosapentaenoic acid (EPA) administration. Levels of expression of the Cide-a and Cide-c genes correlated well with plasma ALT. EPA inhibited the promoter activity of the Cide-a gene in vitro. Sterol regulatory element-binding protein-1 (SREBP-1) markedly enhanced the promoter activity of Cide-a, and EPA inhibited the expression of Cide-a mRNA. SREBP-1 and EPA did not affect those of Cide-c. These findings indicate that Cide-a and Cide-c are closely involved in the progression of hepatic steatosis, and that EPA inhibits Cide-a gene expression through SREBP-1 regulation.

Keywords: Cide-a, Cide-c, SREBP-1, EPA, Steatosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0952-3278(10)00107-9

doi:10.1016/j.plefa.2010.05.002

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 2 , Pages 75-81, August 2010